https://ansm.sante.fr/actualites/lansm-publie-le-rapport-dactivite-dhemovigilance-2022

https://www.ema.europa.eu/en/human-regulatory/post-authorisation/pharmacovigilance/signal-management/prac-recommendations-safety-signals

https://www.ema.europa.eu/en/news/getting-ready-emas-website-relaunch-5-december-2023

https://ansm.sante.fr/actualites/joint-action-on-market-surveillance-jams-2-0-leurope-a-lansm-les-14-et-15-novembre-2023

https://ansm.sante.fr/actualites/un-engagement-de-tous-les-acteurs-pour-lutter-contre-le-mesusage-des-medicaments

https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-6-9-november-2023

https://laegemiddelstyrelsen.dk/en/licensing/clinical-trials/new-european-clinical-trial-regulation-from-the-31th-january-2022/

https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-23-26-october-2023